Organizations can operate more productively and effectively thanks to information technology. The preservation of records, quicker communication, and electronic storage are the main benefits. Pharmaceutical IT services are available to businesses of all sizes and can assist in overcoming the difficulties associated with drug development. The development of pharmaceutical ERP software has made it simple to run your company more effectively. Pharmaceutical software solutions are easy to install and aid firms in efficiently meeting standards. They can raise the calibre of the goods. Information technology improves decision-making and gives access to precise, real-time data to those in the pharmaceutical industry.
In the ever-evolving realm of pharmaceutical research and development (R&D), the powerful wave of digitalization is restructuring conventional methodologies and paving the way for a novel era of ingenuity and streamlined processes
In drug discovery, AI is being used to predict the efficacy and safety of potential drug candidates, identify new therapeutic targets, and optimize clinical trial designs.
The concepts of Big Data and Big Data Analytics have been around for some time but it has only been since the late 1990’s, with the confluence of genomic and transcriptomic data, along with increased use of EHR’s and access to claims data, that Big Data has arrived at the shores of pharma and healthcare.
Digital transformation in the pharma industry involves the use of technology to streamline operations, enhance patient engagement, and improve the efficiency of clinical trials.
Causality assessment is a crucial process in safety vigilance that involves determining the relationship between a drug and an adverse event or reaction.
Nanomaterials have been one of the most exciting scientific and technical innovations of the past few decades. Due to their very high surface to volume ratios, they exhibit properties that can differ dramatically from those for the same material in bulk.
The application of data science in the pharmaceutical industry has far-reaching consequences for individuals considering a degree in this discipline. Important statistical data acquired from several sources is regularly used by the pharmaceutical sector.
Soft gels, also known as soft capsules or soft caps, are a highly popular pharmaceutical and nutraceutical dosage form, with around 2,500 units consumed every second globally. A forecast by HJR Research predicts a CAGR of 5.5 per cent over the next decade, with the global market value expected to reach $756 billion by 2025. During the same period,...
Imagine checking into a hotel late in the night but not being able to get the room you had so carefully chosen because the call centre didn’t align with the hotel on the specification! Customers in such scenarios find themselves at a loss for venting out their frustration and social media seems a good refuge.
Billions of dollars are invested every year into the discovery and development of new medicines, but it usually takes 10-15 years for a drug or vaccine to evolve from inception to release.
While the life sciences sector has incrementally adopted digital technologies over the years, the rate of digital transformation over the next five years looks to be unprecedented.
At the heart of almost all life science and pharmaceutical industry operations are digital information and document handling systems. From the earliest clinical phases to the last post-approval study, the data and technical documentation these systems manage are essential to the safe, effective creation of medicines and therapeutics for all patient...
Despite great effort and expense implementing data-driven business models and processes, the biopharma industry’s attempts to digitally transform operations are returning mixed results.
Pharmacovigilance (PV) is increasingly taking its toll on life science organisations.
During recent decades, biopharmaceuticals, such as monoclonal antibodies, peptides or nucleic acids, have gained impressive attention as revolutionary therapeutics and vaccine strategies, attempting to fulfil the high expectations of resolving serious health conditions. Regarding nucleic acids, DNA- and mRNA-based technologies have been established...
